ArticleFrontiers in oncology2023

Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC).

Qin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.